130 related articles for article (PubMed ID: 33608452)
21. [Clinical analysis of 32 cases with neuroendocrine carcinoma of the uterine cervix in early-stage disease].
Wang Z; Wu L; Yao H; Sun Y; Li X; Li B; Zhang R; Ma S; Huang M
Zhonghua Fu Chan Ke Za Zhi; 2015 Mar; 50(3):198-203. PubMed ID: 26268410
[TBL] [Abstract][Full Text] [Related]
22. Early cervical adenocarcinoma: selection criteria for radical surgery.
Schorge JO; Lee KR; Lee SJ; Flynn CE; Goodman A; Sheets EE
Obstet Gynecol; 1999 Sep; 94(3):386-90. PubMed ID: 10472864
[TBL] [Abstract][Full Text] [Related]
23. Number of Removed Pelvic Lymph Nodes as a Prognostic Marker in FIGO Stage IB1 Cervical Cancer with Negative Lymph Nodes.
Wang R; Tao X; Wu X; Jiang H; Xia H
J Minim Invasive Gynecol; 2020; 27(4):946-952. PubMed ID: 31394263
[TBL] [Abstract][Full Text] [Related]
24. Microinvasive cervical adenocarcinoma (FIGO stage 1A tumors): results of surgical staging and outcome analysis.
Ceballos KM; Shaw D; Daya D
Am J Surg Pathol; 2006 Mar; 30(3):370-4. PubMed ID: 16538058
[TBL] [Abstract][Full Text] [Related]
25. [Villograndular adenocarcinoma of uterine cervix: a case report].
Reale D; Vitullo G; Di Virgilio M; Trubiani O; Pizzicannella G
Pathologica; 2001 Apr; 93(2):128-31. PubMed ID: 11428290
[TBL] [Abstract][Full Text] [Related]
26. Laparoscopic nerve-sparing radical hysterectomy without uterine manipulator for cervical cancer stage IB: description of the technique, our experience and results after the era of LACC trial.
Kavallaris A; Chalvatzas N; Gkoutzioulis A; Zygouris D
Arch Gynecol Obstet; 2021 Apr; 303(4):1039-1047. PubMed ID: 33068159
[TBL] [Abstract][Full Text] [Related]
27. Villoglandular papillary adenocarcinoma of the uterine cervix.
Collinet P; Prolongeau JF; Vaneecloo S
Eur J Obstet Gynecol Reprod Biol; 1999 Sep; 86(1):101-3. PubMed ID: 10471150
[TBL] [Abstract][Full Text] [Related]
28. Prognostic Parameters for Patients with Cervical Cancer FIGO Stages IA2-IIB: A Long-Term Follow-Up.
Obrzut B; Semczuk A; Naróg M; Obrzut M; Król P
Oncology; 2017; 93(2):106-114. PubMed ID: 28463843
[TBL] [Abstract][Full Text] [Related]
29. The clinicopathologic and immunohistochemical features of villoglandular adenocarcinoma of uterine cervix.
Huang ZY; Zhang S; Zhang YZ; An JH; Luo J; Liao PJ; Chen Q; Shen H
Indian J Pathol Microbiol; 2018; 61(4):549-552. PubMed ID: 30303146
[TBL] [Abstract][Full Text] [Related]
30. Villoglandular papillary adenocarcinoma of the cervix: a series of 28 cases including two with lymph node metastasis.
Lataifeh IM; Al-Hussaini M; Uzan C; Jaradat I; Duvillard P; Morice P
Int J Gynecol Cancer; 2013 Jun; 23(5):900-5. PubMed ID: 23552807
[TBL] [Abstract][Full Text] [Related]
31. [Villous glandular adenocarcinoma of the uterine cervix. A subtype with favourable prognosis?].
Reed W; Abeler VM; Tropé CG
Tidsskr Nor Laegeforen; 1993 Aug; 113(20):2569-71. PubMed ID: 8236177
[TBL] [Abstract][Full Text] [Related]
32. Radical vaginal hysterectomy with extraperitoneal pelvic lymphadenectomy in cervical cancer.
Savino L; Borruto F; Comparetto C; Massi GB
Eur J Gynaecol Oncol; 2001; 22(1):31-5. PubMed ID: 11321490
[TBL] [Abstract][Full Text] [Related]
33. Clinicopathological characteristics and prognostic factors of cervical adenocarcinoma.
Wang M; Yuan B; Zhou ZH; Han WW
Sci Rep; 2021 Apr; 11(1):7506. PubMed ID: 33820927
[TBL] [Abstract][Full Text] [Related]
34. Laparoscopic transperitoneal infrarenal para-aortic lymphadenectomy in patients with FIGO stage IB1-II B cervical carcinoma.
Hong DG; Park NY; Chong GO; Cho YL; Park IS; Lee YS; Lee DH
JSLS; 2012; 16(2):229-35. PubMed ID: 23477170
[TBL] [Abstract][Full Text] [Related]
35. Surgical treatment and outcome of early invasive adenocarcinoma of the uterine cervix (FIGO stage IA1).
Yahata H; Sonoda K; Yasunaga M; Ohgami T; Kawano Y; Kaneki E; Okugawa K; Kaku T; Kato K
Asia Pac J Clin Oncol; 2018 Apr; 14(2):e50-e53. PubMed ID: 28429457
[TBL] [Abstract][Full Text] [Related]
36. Do FIGO stage IA and small (≤2 cm) IB1 cervical adenocarcinomas have a good prognosis and warrant less radical surgery?
Al-Kalbani M; McVeigh G; Nagar H; McCluggage WG
Int J Gynecol Cancer; 2012 Feb; 22(2):291-5. PubMed ID: 22080884
[TBL] [Abstract][Full Text] [Related]
37. Prognostic factors in definitive radiotherapy of uterine cervical cancer.
Yalman D; Aras AB; Ozkök S; Duransoy A; Celik OK; Ozsaran Z; Haydaroğlu A
Eur J Gynaecol Oncol; 2003; 24(3-4):309-14. PubMed ID: 12807246
[TBL] [Abstract][Full Text] [Related]
38. [Efficacy and safety of laparoscopic radical hysterectomy for early cervical adenocarcinoma].
Zhang YN; Li B; Wang YT; Liu SH
Zhonghua Fu Chan Ke Za Zhi; 2020 Sep; 55(9):600-608. PubMed ID: 32957748
[No Abstract] [Full Text] [Related]
39. Vaginal fertility-sparing surgery and laparoscopic sentinel lymph node detection in early cervical cancer. Retrospective study with 15 years of follow-up.
Gil-Ibañez B; Glickman A; Del Pino M; Boada D; Fuste P; Diaz-Feijoo B; Pahisa J; Torne A
Eur J Obstet Gynecol Reprod Biol; 2020 Aug; 251():23-27. PubMed ID: 32480177
[TBL] [Abstract][Full Text] [Related]
40. Villoglandular papillary adenocarcinoma of the uterine cervix with aggressive clinical course--a case report.
Rubesa-Mihaljević R; Vrdoljak-Mozetic D; Ostojić DV; Stemberger-Papić S; Sindik N; Krasević M
Coll Antropol; 2010 Mar; 34(1):291-4. PubMed ID: 20437645
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
